Infection-Chronic Disease Link

In "The Infection-Chronic Disease Link Strengthens,"1 there are comments about the utility of Koch's postulates: "The first criterion remains--the microbial culprit must be present. But the requirements to culture microorganisms and demonstrate infectivity may have become obsolete." This would almost seem to go against the scientific method, since it seems to imply that testing one's hypothesis does not require exhaustive attempts at falsification, the fundamental basis of the scientific

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In "The Infection-Chronic Disease Link Strengthens,"1 there are comments about the utility of Koch's postulates: "The first criterion remains--the microbial culprit must be present. But the requirements to culture microorganisms and demonstrate infectivity may have become obsolete."

This would almost seem to go against the scientific method, since it seems to imply that testing one's hypothesis does not require exhaustive attempts at falsification, the fundamental basis of the scientific method. Why would scientists NOT want to demonstrate infectivity of an agent that they propose is indeed infectious? Koch's postulates have served us very well for over 100 years. Is it that they are really obsolete, or do scientists really need an explanation for their inability to demonstrate infectivity of their hypothetical pathogenic microbes? Are there too many dollars at stake to apply standard, rigorous scientific standards?

I think it is a slippery slope to start dismissing established postulates, which essentially ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Todd Miller

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio